SmarterDividends
JHPC

Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR

JHPCY

Healthcare · Stock · annual payer

$13.60

Overvalued · -60% Add to Portfolio

Forward Yield

0.43%

Annual Dividend

$0.06

Payout Ratio

0%

5-Yr Growth

Ex-Date

Apr 30, 2026

Frequency

Annual

Summary

As of July 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR (JHPCY) yields 0.43% ($0.06 per share annually), with a blended fair-value estimate of $5.45 — -60% downside, so it screens as overvalued.

Is JHPCY a good dividend stock?

Mixed

Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR (JHPCY) pays a annual dividend yielding 0.43% ($0.06/yr), with 0 years of growth. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.

Advantages

  • Never cut its dividend on record

Risks

  • Single-stock concentration risk — diversify

Key Data

Dividend Yield
0.43%
Payout Ratio
0%
Annual Dividend
$0.06
5-Yr Avg Growth
Ex-Dividend Date
Apr 30, 2026
Years of Growth
0
Frequency
annual
Beta
0.12
Market Cap
$45.1B
P/E Ratio
37.8
5-Yr Total Return
52-Week Range
$13.60 – $18.00
Dividend Safety
Ever Cut?
No
JHPCY ex-dividend date & scheduleNext ex-date Apr 30, 2026 · full ex-dividend historyView →

Frequently Asked Questions

Income Calculator

At $0.06 / yr per share

Per payment (annual)$6.00
Annual$6.00
Monthly avg$0.50